- Home
- ASBP vs HKPD Comparison
ASBP vs HKPD Comparison
Compare ASBP & HKPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASBP | HKPD |
|---|---|---|
| Founded | 2021 | 2016 |
| Country | United States | Hong Kong |
| Employees | N/A | 27 |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Pharmaceuticals |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.6M | 6.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | ASBP | HKPD |
|---|---|---|
| Price | $0.57 | $0.68 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 155.7K | 24.5K |
| Earning Date | 03-31-2026 | 08-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.05 | $0.58 |
| 52 Week High | $2.45 | $2.74 |
Technical Indicators
Market Signals| Indicator | ASBP | HKPD |
|---|---|---|
| Relative Strength Index (RSI) | 26.74 | 42.06 |
| Support Level | $0.32 | N/A |
| Resistance Level | $0.88 | $0.89 |
| Average True Range (ATR) | 0.15 | 0.05 |
| MACD | -0.09 | 0.00 |
| Stochastic Oscillator | 3.13 | 43.51 |
Price Performance
Historical ComparisonAbout ASBP Aspire Biopharma Holdings Inc.
Aspire Biopharma Holdings Inc developing next-generation absorption of medicine that will have an impact on the opioid crisis. The group engaged in the business of developing and marketing disruptive technology for novel delivery mechanisms for do-no-harm drugs. Its nanotechnology drug formulation directly targets pain and inflammation bypassing the gastrointestinal tracts.
About HKPD Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Cellyan Biotechnology Co Ltd formerly, Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.